» Articles » PMID: 2808700

A Patient with Platelets Deficient in Glycoprotein VI That Lack Both Collagen-induced Aggregation and Adhesion

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1989 Nov 1
PMID 2808700
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular level studies on platelets deficient in collagen-induced aggregation provide evidence for identifying possible platelet collagen receptors. We investigated platelets from a patient with mild bleeding time prolongation, but otherwise normal coagulation data. Her platelets lacked collagen-induced aggregation and adhesion, but retained normal aggregation and release by other agonists. Labeling her platelets with 125I or 3H and analysis by SDS-PAGE/autoradiography showed normal levels of glycoproteins Ia, Ib, IIa, IIb, IIIa, and IV. However, there were significantly decreased incorporations of both radioactivities into a 61-kD membrane glycoprotein (GP), which was identified as GPVI from its mobility on unreduced-reduced, two-dimensional SDS-PAGE. Sugiyama et al. (1987. Blood. 69: 1712) reported that the serum from an idiopathic thrombocytopenic purpura (ITP) patient contained an antibody against a 62-kD platelet protein. Our patient's platelets lacked the antigen for the ITP patient's antibody, demonstrating that the ITP serum contains a specific antibody against GPVI. The patient's parents' platelets contained approximately 50% the normal amount of GPVI, but still had normal collagen-induced aggregation and adhesion. The patient's platelets did not bind to types I and III collagen fibrils. Our results suggest that GPVI functions as a collagen receptor.

Citing Articles

STEMI Antithrombotic Therapy: The Evolving Role of P2Y12 Inhibitor Pretreatment in Contemporary Practice.

Tommasino A, Fiorentini V, Mattaroccia G, Scoccia A, Barbato E Rev Cardiovasc Med. 2024; 25(11):416.

PMID: 39618847 PMC: 11607508. DOI: 10.31083/j.rcm2511416.


Molecular mechanisms driving the interactions between platelet and gastric cancer cells during peritoneal dissemination.

Nakayama T, Saito R, Furuya S, Higuchi Y, Matsuoka K, Takahashi K Oncol Lett. 2024; 28(4):498.

PMID: 39211304 PMC: 11358723. DOI: 10.3892/ol.2024.14631.


Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome.

Yamamoto A, Nishimori H, Shirai T, Takano K, Komura A, Kambara Y Intern Med. 2024; 63(13):1917-1922.

PMID: 38945933 PMC: 11272510. DOI: 10.2169/internalmedicine.2799-23.


GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease.

Slater A, Khattak S, Thomas M Eur Heart J Cardiovasc Pharmacother. 2024; 10(5):465-473.

PMID: 38453424 PMC: 11323372. DOI: 10.1093/ehjcvp/pvae018.


Inhibition of cancer cell‑platelet adhesion as a promising therapeutic target for preventing peritoneal dissemination of gastric cancer.

Nakayama T, Saito R, Furuya S, Shoda K, Maruyma S, Takiguchi K Oncol Lett. 2023; 26(6):538.

PMID: 38020309 PMC: 10655057. DOI: 10.3892/ol.2023.14125.


References
1.
Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H . A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood. 1987; 69(6):1712-20. View

2.
Jung S, Yoshida N, Aoki N, Tanoue K, Yamazaki H, Moroi M . Thrombasthenia with an abnormal platelet membrane glycoprotein IIb of different molecular weight. Blood. 1988; 71(4):915-22. View

3.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

4.
Jamieson G, Urban C, Barber A . Enzymatic basis for platelet: collagen adhesion as the primary step in haemostasis. Nat New Biol. 1971; 234(44):5-7. DOI: 10.1038/newbio234005a0. View

5.
Phillips D . Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry. 1972; 11(24):4582-8. DOI: 10.1021/bi00774a025. View